The Copenhagen Stock Exchange's OMXC20 index climbed 1.3% on August 25 to 1,662.27, bringing its weekly gain to 1.66%. The index has seen steady positive momentum over the week. The OMXC20 is heavily influenced by its largest constituent, Novo Nordisk, whose performance as a global pharmaceutical company drives a significant share of index returns.
Aug 25, 17:51 UTCغرفة أخبار AlternativeMarkets.AI · البيانات: Financial Modeling Prep
Denmark's OMXC20 index gained 1.97% to 1,599.64 on August 09, while its weekly performance was essentially flat at +0.06%. The daily advance brought the index close to the 1,600 level without materially changing its position over the week. The OMXC20 is heavily influenced by its large pharmaceutical and shipping constituents, so sector-specific news often drives outsized moves.
Aug 09, 17:51 UTCغرفة أخبار AlternativeMarkets.AI · البيانات: Financial Modeling Prep
Denmark's OMXC20 index gained 1.97% to 1,599.64 on August 08, though the weekly advance was minimal at just 0.06%. The daily move stands in contrast to a largely flat week for the index. The OMXC20 is dominated by a small number of large-cap companies, particularly in pharmaceuticals and shipping, which can cause the index to diverge from broader European equity trends.
Aug 08, 17:51 UTCغرفة أخبار AlternativeMarkets.AI · البيانات: Financial Modeling Prep
Denmark's OMXC20 index advanced 1.97% to 1,599.64 on August 7, though the weekly return remained negative at -1.88%. The session rally recovered part of earlier weekly losses without fully reversing them. The index is heavily concentrated in pharmaceutical and healthcare stocks, with Novo Nordisk representing a particularly large share of the benchmark's total weight.
Aug 07, 17:51 UTCغرفة أخبار AlternativeMarkets.AI · البيانات: Financial Modeling Prep